Brandywine Global Investment Management LLC Cuts Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Brandywine Global Investment Management LLC lessened its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 7.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 77,046 shares of the company’s stock after selling 5,960 shares during the quarter. Brandywine Global Investment Management LLC owned 0.06% of Henry Schein worth $5,332,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Norges Bank purchased a new stake in shares of Henry Schein in the fourth quarter valued at approximately $103,301,000. Holocene Advisors LP purchased a new stake in shares of Henry Schein during the 3rd quarter worth $58,319,000. Raymond James Financial Inc. acquired a new position in shares of Henry Schein during the 4th quarter worth $34,720,000. National Bank of Canada FI increased its holdings in shares of Henry Schein by 1,124.5% in the 3rd quarter. National Bank of Canada FI now owns 535,950 shares of the company’s stock valued at $39,071,000 after purchasing an additional 492,181 shares in the last quarter. Finally, ING Groep NV lifted its stake in shares of Henry Schein by 34.1% in the fourth quarter. ING Groep NV now owns 1,163,087 shares of the company’s stock valued at $80,486,000 after purchasing an additional 295,785 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Finally, Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Stock Up 0.8 %

Shares of NASDAQ HSIC opened at $69.07 on Wednesday. The firm has a market cap of $8.58 billion, a P/E ratio of 28.42, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49. The firm’s 50 day moving average price is $74.42 and its 200 day moving average price is $72.67.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.66 EPS. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.